Reduced embolic complications with Novacor LVAS: A multicenter experience

Elefteriades, John A.; El-Banayosy, A; Noirhomme, P.; Vitali, Ettore; Reichart, B.; Lansman, Steven L.; Hendry, P. O.; Kasirajan, Vigneshwar

doi:10.1016/j.healun.2004.11.205

The Journal of Heart and Lung Transplantation

2005

DOI: 10.1016/j.healun.2004.11.205

|View full text |Cite

Reduced embolic complications with Novacor LVAS: A multicenter experience

John A. Elefteriades¹,

A El-Banayosy²,

P. Noirhomme³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2006

2007

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Since completion of the INTrEPID trial, the Novacor LVAD inflow conduit material has been changed to ePTFE, eliminating pannus formation. This modification reduced the stroke rate to 5.3% in a series of 57 LVAD recipients supported for a cumulative duration of 53.5 years (15).…”

mentioning

confidence: 99%

Chronic Mechanical Circulatory Support for Inotrope-Dependent Heart Failure Patients Who Are Not Transplant Candidates

Rogers

Butler

Lansman

et al. 2007

Journal of the American College of Cardiology

305

169

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Chronic Mechanical Circulatory Support for Inotrope-Dependent Heart Failure Patients Who Are Not Transplant Candidates

Rogers

Butler

Lansman

et al. 2007

Journal of the American College of Cardiology

305

169

View full text Add to dashboard Cite

show abstract

Relationship Between Renal Function and Left Ventricular Assist Device Use

Butler

Geisberg

Howser

et al. 2006

The Annals of Thoracic Surgery

122

104

View full text Add to dashboard Cite

Assisted circulation: experience with the Novacor^®Left Ventricular Assist System

Farkas

Elefteriades²

2007

Expert Review of Medical Devices

View full text Add to dashboard Cite

Surgical therapy for the treatment of heart failure is a relatively young solution to a problem that has overwhelmed civilizations dating back to the First Dynasty. Despite centuries of enormous multidisciplinary medical and technological advance, nearly 2000 people in the USA died of cardiovascular disease every day in 2006, averaging one death every 35 seconds, and claiming more lives than the next four leading causes of death combined. In 2007, one in 30 female deaths will be from breast cancer, while one in 2.6 will be from cardiovascular disease. The prevalence of heart failure in our population is a staggering 5 million in the USA and 6.5 million in Europe per year. Furthermore, based on the 44-year follow-up of the National Heart, Blood, and Lungs Institute Framingham Heart Study, 80% of men and 70% of women under the age of 65 years who have heart failure will die within 8 years. The focus of this article will be to review the history and future of the Novacor Left Ventricular Assist System as it relates to the failing heart; the story of how the innovator, the researcher, the engineer and the surgeon have come together to offer a surgical solution to a medical problem of inconceivable scope.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Reduced embolic complications with Novacor LVAS: A multicenter experience

Cited by 3 publications

References 0 publications

Chronic Mechanical Circulatory Support for Inotrope-Dependent Heart Failure Patients Who Are Not Transplant Candidates

Chronic Mechanical Circulatory Support for Inotrope-Dependent Heart Failure Patients Who Are Not Transplant Candidates

Relationship Between Renal Function and Left Ventricular Assist Device Use

Assisted circulation: experience with the Novacor^®Left Ventricular Assist System

Contact Info

Product

Resources

About

Reduced embolic complications with Novacor LVAS: A multicenter experience

Cited by 3 publications

References 0 publications

Chronic Mechanical Circulatory Support for Inotrope-Dependent Heart Failure Patients Who Are Not Transplant Candidates

Chronic Mechanical Circulatory Support for Inotrope-Dependent Heart Failure Patients Who Are Not Transplant Candidates

Relationship Between Renal Function and Left Ventricular Assist Device Use

Assisted circulation: experience with the Novacor®Left Ventricular Assist System

Contact Info

Product

Resources

About

Assisted circulation: experience with the Novacor^®Left Ventricular Assist System